Controlled Synthesis of the FeB Nanometallic Glasses with Stronger Electron Donating Capability to Activate Molecular Oxygen for the Enhanced Ferroptosis Therapy
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202403582 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Gongyu Shi und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Center of Free Electron Laser & High Magnetic Field, Key Laboratory of Structure and Functional Regulat…. Hauptthemen laut MEDLINE: Ferroptosis, Oxygen, Iron, Glass. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, The University Annual Scientific Research Plan of Anhui Province.
Abstract (Originalsprache)
Considering the strong electron‐donating ability and the superior biocompatibility, the integration of zero‐valent iron nanostructure Fe 0 (electron‐reservoir) and zero‐valent boron nanostructure B 0 offers great promise for fabricating novel ferroptosis nanoagents. Nevertheless, the controlled and facile synthesis of alloyed Fe 0 and B 0 nanostructure‐FeB nanometallic glasses (NMGs) has remained a long‐standing challenge. Herein, a complexion‐reduction strategy is proposed for the controlled synthesis of FeB NMGs with greater electron donating capacity to activate the molecular oxygen for improved ferroptosis therapy. In‐depth mechanism reveales that the complexion‐reduction strategy effectively prevent the long‐range diffusion of Fe 0 , resulting in the amorphous alloyed Fe 0 and B 0 nanostructure‐FeB nanoparticles (FeB NPs). The FeB NPs display stronger electron donating capability and electron transfer rate 9.4 times higher than that of the Fe 0 NPs, which effectively activate the molecular oxygen to produce ∙O 2 − , H 2 O 2 and ∙OH. The in vitro cellular experiments confirm the FeB‐ss‐SiO₂ NPs (encapsulation with SiO 2 outlayer containing ‐S‐S‐ bonds) demonstrates the enhanced ferroptosis. The tumor‐bearing mice models shows that FeB‐ss‐SiO₂ NPs exhibited superior biocompatibility and tumor inhibition effect (inhibition rate of 73%), which improve the overall survival rate for 30 days post‐treatment. This study will provide an innovative way to design therapeutic nanoagents for cancer treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Chemical Engineering, Center of Free Electron Laser & High Magnetic Field, Key Laboratory of Structure and Functional Regulation of Hybrid Materials Ministry of Education, Key Laboratory of Funct…
- Anhui Province Key Laboratory of Advanced Catalytic Materials and Reaction Engineering, School of Chemistry and Chemical Engineering, Hefei University of Technology, Hefei, 230026, P.R.China.
- School of Chemical and Environmental Engineering, Anhui Polytechnic University, Wuhu, 241000, P. R. China.
ORCID-Profile: Xiaojiao Zhu
Förderung
- National Natural Science Foundation of China
- The University Annual Scientific Research Plan of Anhui Province
Zitieren
APA
Shi, G., Zhang, Y., Wang, W., Xiang, W., Zhang, F., Zhu, X., & Zhou, H. (2025). Controlled Synthesis of the FeB Nanometallic Glasses with Stronger Electron Donating Capability to Activate Molecular Oxygen for the Enhanced Ferroptosis Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202403582
Vancouver
Shi G, Zhang Y, Wang W, Xiang W, Zhang F, Zhu X, et al. Controlled Synthesis of the FeB Nanometallic Glasses with Stronger Electron Donating Capability to Activate Molecular Oxygen for the Enhanced Ferroptosis Therapy. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202403582
BibTeX
@article{Shi2025,
author = {Shi, Gongyu and Zhang, Yongxuan and Wang, Wenting and Xiang, Wanxuan and Zhang, Feng and Zhu, Xiaojiao and Zhou, Hongping},
title = {Controlled Synthesis of the FeB Nanometallic Glasses with Stronger Electron Donating Capability to Activate Molecular Oxygen for the Enhanced Ferroptosis Therapy},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202403582}
}
EUVIMED